Rare diseases
Investigational molecules
Locations
237 conditions with trials, the busiest first
741 trials across Europe, recruiting first
Evaluation of gaxilose (LacTEST 0.45 g) as a marker of intestinal barrier integrity in patients with celiac disease
SpainSafety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency
IrelandAtorvastatin, Placebo, and No Treatment in Adults with Familial Hypercholesterolaemia and Statin-Associated Muscle Symptoms
NorwayEffect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease
ItalyA study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes
CroatiaStudy evaluating the effects of palopegteriparatide and alfacalcidol on quality of life and brain function in patients with hypoparathyroidism
DenmarkFeasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency
SwedenComparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis
FinlandStudy of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes
ItalyStudy of the effectiveness and safety of tirzepatide for treating obesity in patients waiting for a liver transplant
CzechiaStudy of anakinra and a drug combination to prevent blood clots in patients receiving a pancreatic transplant
FranceA study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism
FranceThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
